Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S, Ozono S, Hirao Y, Okajima E
Department of Urology, Nara Medical University, Japan.
Urol Res. 1987;15(6):329-34. doi: 10.1007/BF00265661.
Chemotherapeutic agents were evaluated for effect on the development of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in male Wistar strain rats. Seven hundred and two rats were given 0.05% BBN in drinking water for 8 weeks. After BBN treatment, the animals were divided into 26 groups to follow regimens of single chemotherapy. All drugs were administered intraperitoneally except in one group that was treated orally. In our experimental series, 5-fluorouracil (5-FU), N-(2-tetrahydrofuryl)-5-fluorouracil (FT-207), carbazilquinone (CQ), vincristine (VCR) and cis-diamminedichloroplatinum (CDDP) were effective in inhibiting the incidence of bladder tumor, however, adriamycin (ADM), mitomycin C (MMC), neocarsinostatin (NCS), cyclophosphamide (CPM) and bleomycin (BLM) were not effective.
对化疗药物进行了评估,以观察其对雄性Wistar品系大鼠中由N-丁基-N-(4-羟丁基)亚硝胺(BBN)诱导的膀胱肿瘤发生发展的影响。702只大鼠饮用含0.05%BBN的水8周。BBN处理后,将动物分成26组,遵循单一化疗方案。除一组经口服给药外,所有药物均经腹腔注射给药。在我们的实验系列中,5-氟尿嘧啶(5-FU)、N-(2-四氢呋喃基)-5-氟尿嘧啶(FT-207)、卡巴醌(CQ)、长春新碱(VCR)和顺二氯二氨铂(CDDP)可有效抑制膀胱肿瘤的发生率,然而,阿霉素(ADM)、丝裂霉素C(MMC)、新制癌菌素(NCS)、环磷酰胺(CPM)和博来霉素(BLM)则无效。